Safety Study of Bevacizumab, Everolimus and LBH589 (BEL) for Advanced Solid Tumors

This study has been completed.
Sponsor:
Collaborators:
Novartis
Genentech, Inc.
Information provided by (Responsible Party):
Herbert Hurwitz, Duke University Medical Center
ClinicalTrials.gov Identifier:
NCT01055795
First received: January 24, 2010
Last updated: December 21, 2012
Last verified: December 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2012
  Primary Completion Date: August 2011 (Final data collection date for primary outcome measure)